Hao G. Nguyen
YOU?
Author Swipe
View article: Entrepreneurial decisions to become affiliate marketing partners: Role of rewards and motivation
Entrepreneurial decisions to become affiliate marketing partners: Role of rewards and motivation Open
Tiêu đề: Quyết định khởi sự trở thành đối tác tiếp thị liên kết: Vai trò của phần thưởng và động lực Tóm tắt: Với sự phát triển của mạng xã hội và các nền tảng kỹ thuật số, thuật ngữ “khởi sự kỹ thuật số” đã xuất hiện cùng với một số mô hì…
View article: 106P Building an Asian patient-derived organoid biobank for precision oncology
106P Building an Asian patient-derived organoid biobank for precision oncology Open
View article: Improving Zero-Shot Object-Level Change Detection by Incorporating Visual Correspondence
Improving Zero-Shot Object-Level Change Detection by Incorporating Visual Correspondence Open
Detecting object-level changes between two images across possibly different views is a core task in many applications that involve visual inspection or camera surveillance. Existing change-detection approaches suffer from three major limit…
View article: TAB: Transformer Attention Bottlenecks enable User Intervention and Debugging in Vision-Language Models
TAB: Transformer Attention Bottlenecks enable User Intervention and Debugging in Vision-Language Models Open
Multi-head self-attention (MHSA) is a key component of Transformers, a widely popular architecture in both language and vision. Multiple heads intuitively enable different parallel processes over the same input. Yet, they also obscure the …
View article: Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma
Pharmacokinetic Comparison of Selective Prostatic Arterial and Intravenous PSMA PET/CT Radioligand Infusions in Primary Prostatic Adenocarcinoma Open
Selective prostatic arterial infusion yielded higher radiotracer uptake in prostatic tumors than intravenous infusions when using dynamic prostate-specific membrane antigen PET/CT to simulate radioligand therapy.
View article: Investigation of phosphorus removal from modified starch wastewater using calcium and magnesium ions
Investigation of phosphorus removal from modified starch wastewater using calcium and magnesium ions Open
Phosphorus pollution poses a significant environmental challenge in wastewater from industries like modified starch production. This study investigates the feasibility of mitigating phosphorus contamination in modified starch production wa…
View article: Systematic Review and Meta-Analysis of Salvage Ablation for Radiation-Recurrent Localized Prostate Cancer – A Focal Therapy Society Project
Systematic Review and Meta-Analysis of Salvage Ablation for Radiation-Recurrent Localized Prostate Cancer – A Focal Therapy Society Project Open
View article: 862 TLR9 agonism promotes cytotoxic T cell persistence and myeloid remodeling when combined with radiation therapy and PD-1 blockade in oligometastatic prostate cancer patients
862 TLR9 agonism promotes cytotoxic T cell persistence and myeloid remodeling when combined with radiation therapy and PD-1 blockade in oligometastatic prostate cancer patients Open
Background Glioblastoma (GBM) is the most aggressive primary brain tumor with a survival rate of 14–16 months. Several ongoing clinical trials employ vaccine, immune checkpoint inhibitors and/or adoptive T cell therapy to treat GBM. Howeve…
View article: The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement
The state of focal therapy in the treatment of prostate cancer: the university of California collaborative (UC-Squared) consensus statement Open
View article: First-in-human Evaluation of a Prostate-specific Membrane Antigen–targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted Prostatectomy
First-in-human Evaluation of a Prostate-specific Membrane Antigen–targeted Near-infrared Fluorescent Small Molecule for Fluorescence-based Identification of Prostate Cancer in Patients with High-risk Prostate Cancer Undergoing Robotic-assisted Prostatectomy Open
IS-002 is a new imaging agent that specifically targets the prostate-specific membrane antigen receptor. In this study, we tested IS-002 for the first time in men with high-risk prostate cancer undergoing surgery and found that IS-002 is s…
View article: Supplementary Methods and Reference from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Methods and Reference from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
Description of additional methods and procedures used in the study. Also includes Supplementary Reference.
View article: Supplementary Figure S4 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Figure S4 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
Function assay of AR variant's constitutive activity in yeast.
View article: Supplementary Figure S5 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Figure S5 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
Immunostaining of AR-V7 in CWR22 xenografts.
View article: Supplementary Figure S2 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Figure S2 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
Quantitative analysis of miR-125b levels in enzalutamide-resistant 22Rv1 (22Rv1-EnzR) cells.
View article: Supplementary Figure S1 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Figure S1 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
The combination treatment with miR-124 and bicalutamide (Bic) significantly inhibited proliferation of C4-2B prostate cancer cells.
View article: Supplementary Methods and Reference from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Methods and Reference from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
Description of additional methods and procedures used in the study. Also includes Supplementary Reference.
View article: Supplementary Figure S4 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Figure S4 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
Function assay of AR variant's constitutive activity in yeast.
View article: Supplementary Figure S2 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Figure S2 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
Quantitative analysis of miR-125b levels in enzalutamide-resistant 22Rv1 (22Rv1-EnzR) cells.
View article: Data from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Data from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
miR-124 targets the androgen receptor (AR) transcript, acting as a tumor suppressor to broadly limit the growth of prostate cancer. In this study, we unraveled the mechanisms through which miR-124 acts in this setting. miR-124 inhibited pr…
View article: Supplementary Figure Legends from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Figure Legends from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
Legend for Supplementary Figures S1-S5.
View article: Supplementary Figure S3 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Figure S3 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
Immunostaining of AR-V7 in miR-124-treated 22Rv1-EnzR cells.
View article: Supplementary Figure S3 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Figure S3 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
Immunostaining of AR-V7 in miR-124-treated 22Rv1-EnzR cells.
View article: Data from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Data from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
miR-124 targets the androgen receptor (AR) transcript, acting as a tumor suppressor to broadly limit the growth of prostate cancer. In this study, we unraveled the mechanisms through which miR-124 acts in this setting. miR-124 inhibited pr…
View article: Supplementary Figure Legends from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Figure Legends from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
Legend for Supplementary Figures S1-S5.
View article: Supplementary Figure S5 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Figure S5 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
Immunostaining of AR-V7 in CWR22 xenografts.
View article: Supplementary Figure S1 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
Supplementary Figure S1 from miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src Open
The combination treatment with miR-124 and bicalutamide (Bic) significantly inhibited proliferation of C4-2B prostate cancer cells.
View article: The natural history of a delayed detectable PSA after radical prostatectomy
The natural history of a delayed detectable PSA after radical prostatectomy Open
Introduction Men with a detectable PSA after radical prostatectomy (RP) are often offered salvage therapy while those with an undetectable PSA are monitored. We aim to better characterize the natural history of men with an initially undete…
View article: Visible Wavelength Flatband in a Gallium Phosphide Metasurface
Visible Wavelength Flatband in a Gallium Phosphide Metasurface Open
Engineering the dispersion of light in a metasurface allows for controlling the light-matter interaction strength between light confined in the metasurface and materials placed within its near-field. Specifically, engineering a flatband di…
View article: Use of Passive Sampling and High-Resolution Mass Spectrometry for Screening Emerging Pesticides of Concern within Surface Waters
Use of Passive Sampling and High-Resolution Mass Spectrometry for Screening Emerging Pesticides of Concern within Surface Waters Open
View article: Use of Passive Sampling and High-Resolution Mass Spectrometry for Screening Emerging Pesticides of Concern within Surface Waters
Use of Passive Sampling and High-Resolution Mass Spectrometry for Screening Emerging Pesticides of Concern within Surface Waters Open